![Kevin Lalande](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Lalande
Oprichter bij
SHVMS, LLC
Profiel
Kevin Myles Lalande is the founder.
He founded SHVMS, LLC in 2006 and holds the title of Founding Managing Director & CIO.
He also founded Terapio Corp.
in 2005 and served as a Director.
In 2016, he founded Santé Capital Management LP and held the title of Founding Managing Director & CIO.
Mr. Lalande is also the founder of Serus LLC, TimeMarker, Inc...
Mr. Lalande's current job(s) include being a Director at LDR Spine USA, Inc., BAROnova, Inc., Ketra, Inc., Lumos Pharma Sub, Inc., and Molecular Templates OpCo, Inc. Mr. Lalande's former job(s) include being a Director at NewLink Genetics Corp., Spinal Restoration, Inc., Protein Discovery, Inc., LDR Holding Corp., Hospitalists Now, Inc., Lyric Pharmaceuticals, Inc., Molecular Templates, Inc., Laguna Pharmaceuticals, Inc., Lumos Pharma, Inc., and AVP Management Services, Inc. Mr. Lalande's education history includes an undergraduate degree from Brigham Young University in 1996 and an MBA from Harvard Business School in 2001.
Actieve functies van Kevin Lalande
| Bedrijven | Functie | Begin |
|---|---|---|
SHVMS, LLC
 SHVMS, LLC Investment ManagersFinance Sante Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical technologies, biotechnology, healthcare services and healthcare IT. It provides financing for seed and early-stage capital requirements. | Oprichter | 01-01-2006 |
BAROnova, Inc.
 BAROnova, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage medical-device company | Directeur/Bestuurslid | - |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Directeur/Bestuurslid | - |
Ketra, Inc.
 Ketra, Inc. Electrical ProductsProducer Manufacturing Provides lighting solutions | Directeur/Bestuurslid | - |
LDR Spine USA, Inc.
 LDR Spine USA, Inc. Medical SpecialtiesHealth Technology Offers sterile spinal implant systems | Directeur/Bestuurslid | - |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Bestuurslid | - |
Eerdere bekende functies van Kevin Lalande
| Bedrijven | Functie | Einde |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Directeur/Bestuurslid | 31-12-2024 |
| LUMOS PHARMA, INC. | Directeur/Bestuurslid | 12-12-2024 |
Santé Capital Management LP
 Santé Capital Management LP Investment ManagersFinance Santé invests at the leading edge of innovation in healthcare and technology to pursue innovative new opportunities with attractive potential returns. The firm employs a systematic investment management process comprised of a three-step cycle: (1) collection and curation of electronic data, (2) relationship analysis and prescriptive analytics, and (3) risk management and a rules-based trading engine | Oprichter | 27-03-2023 |
| ░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Kevin Lalande
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
78
Eerstegraads connecties
23
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 23 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Spinal Restoration, Inc.
 Spinal Restoration, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development of early intervention, minimally invasive therapies for the treatment of chronic low back pain | Health Technology |
LDR Spine USA, Inc.
LDR Spine USA, Inc. Medical SpecialtiesHealth Technology Offers sterile spinal implant systems | Health Technology |
Protein Discovery, Inc.
 Protein Discovery, Inc. BiotechnologyHealth Technology Develops and designs bioanalysis, drug discovery and medical diagnostics systems | Health Technology |
LDR Holding Corp.
 LDR Holding Corp. Medical SpecialtiesHealth Technology Engages in designing and commercializing of novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders | Health Technology |
BAROnova, Inc.
BAROnova, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage medical-device company | Health Technology |
Hospitalists Now, Inc.
 Hospitalists Now, Inc. Miscellaneous Commercial ServicesCommercial Services Offers customized hospitalist services | Commercial Services |
Lyric Pharmaceuticals, Inc.
 Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel gastrointestinal therapeutics | Health Technology |
Serus LLC
 Serus LLC Information Technology ServicesTechnology Services Develops Java-based Web site development and Web page editing technologies | Technology Services |
TimeMarker, Inc.
 TimeMarker, Inc. Information Technology ServicesTechnology Services Develops wireless Internet exchange technology | Technology Services |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SHVMS, LLC
SHVMS, LLC Investment ManagersFinance Sante Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical technologies, biotechnology, healthcare services and healthcare IT. It provides financing for seed and early-stage capital requirements. | Finance |
AVP Management Services, Inc.
 AVP Management Services, Inc. Investment ManagersFinance AVP Management Services invests in middle market companies primarily located in Texas with a revenue of USD 50 to USD 400 million and an EBITDA of USD 10 to USD 40 million. The firm focuses across a broad range of sectors. It participates in seed, early and growth capital requirements with an investment size ranging from USD 25 - USD 75 million for middle market and USD 10 to USD 80 million for early stage. | Finance |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Health Technology |
Terapio Corp.
 Terapio Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics based on the RLIP76 protein | Health Technology |
Laguna Pharmaceuticals, Inc.
 Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Ketra, Inc.
Ketra, Inc. Electrical ProductsProducer Manufacturing Provides lighting solutions | Producer Manufacturing |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Health Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santé Capital Management LP
Santé Capital Management LP Investment ManagersFinance Santé invests at the leading edge of innovation in healthcare and technology to pursue innovative new opportunities with attractive potential returns. The firm employs a systematic investment management process comprised of a three-step cycle: (1) collection and curation of electronic data, (2) relationship analysis and prescriptive analytics, and (3) risk management and a rules-based trading engine | Finance |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
